Pricing
  1. US-listed companies
  2. Arcadia Biosciences, Inc.
  3. Financials
  4. Return on equity (%)

Arcadia Biosciences, Inc. (RKDA)

Market cap
$2.52M
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Dec 31, 2024-73.8-10.58%
Dec 31, 2023-82.6+40.25%
Dec 31, 2022-58.9+19.99%
Dec 31, 2021-49.1+94.34%
Dec 31, 2020-25.2-90.73%
Dec 31, 2019-272.5+110.46%
Dec 31, 2018-129.5+24.50%
Dec 31, 2017-104+65.42%
Dec 31, 2016-62.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat